A leading climate scientist from the University of Bristol, has today won an award in recognition of his pioneering work to advance understanding of global weather extremes and their impact on society.
People with type 2 diabetes who took part in a diet-assisted weight loss trial, showed differences across a wide range of potential biomarkers of metabolic health one year later, according to the results of a new study.
University of Bristol-led research comparing the effectiveness and safety of different types of moisturiser for childhood eczema has won the Royal College of General Practitioners (RCGP) Research Paper of the Year (RPY) Award 2022.
A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions. Results from the University of Bristol-led clinical trial are published today [20 October] in the Journal of Internal Medicine.
New research led by the University of Bristol aims to help GPs choose the best antibiotic for treating urinary tract infections (UTIs) and reducing antimicrobial resistance (AMR), thanks to a £3 million award by the National Institute for Health and Care Research (NIHR).
The UK government's levelling up agenda is set to fail in its mission to address inequalities unless it tackles the root causes of poor health, according to a new study.
Long Covid, which affects nearly two million people in the UK, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that immune activation may persist for months after COVID-19.
Primary care professionals should think beyond thrush and genitourinary symptoms of menopause (GSM) when women present with vulval symptoms and consider the diagnosis of vulval lichen sclerosus (VLS), research led by the University of Bristol suggests.
An inclusive and collaborative exploration of the wider effects of climate change on animal and human health was held on 21 June 2023 at the University of Bristol.
Early warning signs of diseases caused by dysfunctional levels of stress hormones could be spotted more easily thanks to a new wearable device developed by endocrine researchers. This is the first time it has been possible to measure changes to people’s stress hormones as they go about normal daily activities, across both day and night. The new collaborative research led by the University of Bristol, University of Birmingham and University of Bergen has the potential to revolutionise how diseases of the stress hormone system are diagnosed and treated.
